<DOC>
	<DOCNO>NCT00004875</DOCNO>
	<brief_summary>RATIONALE : Heparin enoxaparin may effective prevent formation blood clot patient cancer undergo surgery remove tumor . PURPOSE : Randomized clinical trial compare effectiveness heparin enoxaparin patient cancer .</brief_summary>
	<brief_title>Heparin Enoxaparin Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine pattern tissue factor pathway inhibitor ( TFPI ) release accord tumor type type anticoagulation ( heparin enoxaparin ) patient cancer . II . Determine incidence portacath clot correlation TFPI releasability patient population . III . Compare anticoagulation drug term releasability TFPI patient population . OUTLINE : This randomize study . Patients stratify accord prior chemotherapy within past 3 week ( yes v ) . Patients randomize one two treatment arm . Arm I : Patients receive single dose standard heparin subcutaneously ( SQ ) follow evaluation tissue factor pathway inhibitor ( TFPI ) response 5 10 minute post injection . Arm II : Patients receive single dose enoxaparin SQ follow evaluation TFPI response arm I . Patients follow monthly 3 month . PROJECTED ACCRUAL : A total 20-200 patient accrue study 6 month .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven malignancy , include lymphomas No leukemia PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Greater 6 month Hematopoietic : Hemoglobin great 8.5 g/dL Platelet count great 100,000/mm3 No history heparin and/or low weight molecular heparin induce thrombocytopenia No history bleed diathesis Hepatic : No history coagulation factor deficiency No hepatic encephalopathy No hepatic failure No cirrhosis No hemophilia Renal : Creatinine le 2.5 mg/dL ( great upper limit normal diabetes mellitus ) Cardiovascular : No New York Heart Association class III IV heart disease No congestive heart failure No uncontrolled hypertension ( i.e. , systolic blood pressure least 180 mmHg diastolic blood pressure least 110 mmHg ) No endocarditis No hemorrhagic stroke No prior concurrent deep vein thrombosis Pulmonary : No prior concurrent pulmonary embolus Other : No know allergy enoxaparin standard heparin No known allergy fish ( e.g. , protamine sulfate ) swine product No active ulcerative disease angiodysplasia gastrointestinal ( GI ) tract active GI bleeding within past 6 month No active significant medical illness major failure organ system No refusal donor blood product secondary religious reason Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Concurrent chemotherapy allow Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : At least 1 month since prior eye , spinal cord , CNS surgery Other : At least 1 day since prior heparin enoxaparin At least 1 week since prior therapeutic coumadin ( prior prophylactic coumadin allow ) No concurrent anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>stage I grade 1 follicular lymphoma</keyword>
	<keyword>stage I grade 2 follicular lymphoma</keyword>
	<keyword>stage I grade 3 follicular lymphoma</keyword>
	<keyword>stage I adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>AIDS-related peripheral/systemic lymphoma</keyword>
	<keyword>AIDS-related primary CNS lymphoma</keyword>
	<keyword>stage I mantle cell lymphoma</keyword>
	<keyword>contiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>contiguous stage II mantle cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>angioimmunoblastic T-cell lymphoma</keyword>
	<keyword>anaplastic large cell lymphoma</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage I marginal zone lymphoma</keyword>
	<keyword>stage I small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>contiguous stage II marginal zone lymphoma</keyword>
	<keyword>contiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>